Laatste nieuws in bio
European Healthtech Companies Struggle to Scale Despite Strong Innovation
Amsterdam, Sunday, 10 May 2026.
European healthtech firms excel at developing breakthrough technologies but face a critical distribution problem that prevents them from becoming global leaders. Despite strong scientific capabilities and clinical relationships, companies cannot achieve commercial repeatability across fragmented European markets with different reimbursement systems, procurement processes, and regulatory requirements. This distribution gap forces promising startups to treat each European country as a separate market entry exercise, consuming valuable time and capital that could fuel growth.
Dutch Startup Raises €1.7 Million to Bring Hospital-Grade Heart Tests to Your Doctor's Office
Netherlands, Sunday, 10 May 2026.
HeartEye’s revolutionary wireless device can perform a complete 12-channel heart scan in under 60 seconds, potentially transforming how cardiac conditions are detected outside hospitals. The Amsterdam-based company secured funding from prominent tech executives and health investors to accelerate market launch of technology that could save lives through earlier detection while reducing healthcare costs by preventing unnecessary hospital referrals.
Dutch Research Giant TNO Shifts Strategy to Bridge Healthcare Innovation Gap
The Hague, Friday, 8 May 2026.
TNO launches major strategic pivot in 2026, moving beyond laboratory research to focus on implementing existing healthcare innovations in real-world medical settings. This shift addresses a critical bottleneck where promising health technologies fail to reach patients due to implementation challenges. The organization aims to reduce pressure on the Netherlands’ strained healthcare system while maintaining affordability through practical deployment of AI diagnostics, digital biomarkers, and remote monitoring technologies already developed but underutilized in practice.
Madagascar Vanilla Farming May Actually Protect Biodiversity, New Study Shows
Wageningen, Thursday, 7 May 2026.
Rice cultivation, not vanilla farming, drives Madagascar’s deforestation according to groundbreaking Wageningen University research published May 6, 2026. The study reveals vanilla grows in small northeastern areas using agroforestry methods that support biodiversity rather than destroy it. Researchers warn misblaming vanilla could reduce farmer incomes and increase forest pressure, while diverting attention from real threats.
Scientists Create Gene-Editing Tool That Targets Only Cancer Cells
Wageningen, Thursday, 7 May 2026.
Wageningen University researchers have engineered ThermoCas9, a CRISPR variant that exploits DNA methylation differences to selectively destroy tumor cells while preserving healthy tissue. This breakthrough represents the first gene-editing technology to use chemical markers as cellular addresses, potentially revolutionizing cancer treatment by eliminating traditional therapy side effects. Clinical applications remain a decade away.
Dutch Scientists Begin Revolutionary Disease-Resistant Potato Trials Using Gene Editing Technology
Wageningen, Thursday, 7 May 2026.
Wageningen University will launch groundbreaking field trials in 2026 testing potatoes modified with New Genomic Techniques to resist devastating diseases like Phytophthora infestans. These trials mark the first since 2015 and could dramatically reduce pesticide use while maintaining crop yields. The timing is crucial as Phytophthora infections have already been reported this season, threatening vulnerable emerging crops. Unlike previous genetic modification attempts that faced lengthy EU approval processes, these NGT-modified potatoes may benefit from new EU legislation exempting such plants from traditional authorization procedures, potentially revolutionizing sustainable agriculture.
